Stay updated on Nivolumab in AML Prevention Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in AML Prevention Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in AML Prevention Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    A 'Results Submitted' status has replaced the previous 'No Results Posted' indicator on the study page for REMAIN (NCT02275533). This shows that trial results have been submitted.
    Difference
    0.3%
    Check dated 2025-11-03T12:48:53.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The page has added a
    Difference
    0.0%
    Check dated 2025-10-20T06:39:43.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    Minor update: new dates and two labeled terms added; several old dates removed. Overall, no substantive changes to core content or pricing.
    Difference
    0.6%
    Check dated 2025-10-13T03:10:46.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Added a government funding notice and an updated version tag (v3.2.0); removed the previous version tag (v3.1.0).
    Difference
    2%
    Check dated 2025-10-05T17:36:18.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    Version bump from v3.0.2 to v3.1.0; core page revision information updated.
    Difference
    0.0%
    Check dated 2025-09-28T10:55:32.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2. Removed the 'Back to Top' link.
    Difference
    0.1%
    Check dated 2025-09-14T00:34:03.000Z thumbnail image

Stay in the know with updates to Nivolumab in AML Prevention Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in AML Prevention Clinical Trial page.